Junbin Qian (@JunbinQian) header
Junbin Qian (@JunbinQian) profile picture

MD PhD, Research Professor. Chromosomal instability, tumor microenvironment and their therapeutic targeting across cancer types.

Hangzhou, China
Joined August 2010
Photo by Junbin Qian (@JunbinQian)Photo by Junbin Qian (@JunbinQian)Photo by Junbin Qian (@JunbinQian)Photo by Junbin Qian (@JunbinQian)Photo by Junbin Qian (@JunbinQian)Photo by Junbin Qian (@JunbinQian)
📢 Excited to share our new paper in @Gut_BMJ! We uncover the TNF‑α/ULBP/NKG2D axis that amplifies microvascular damage in Severe Acute Pancreatitis, a disease with high mortality. Promising therapeutic target! 🔗[gut.bmj.com/content/early/20…] #Gastroenterology #Pancreatology #SAP
2
4
1,751
Determining "over-correction" of single-cell data integration is an unmet need. We found the stably expressed "housekeeping genes" can be used to identify over-correction, our RBET tool can provide assurance for multi-omics research with big integration. nature.com/articles/s42003-0…
2
93
Junbin Qian retweeted
Delighted to share a chemical-genetic system we developed to rapidly inhibit a serine/threonine phosphatase complex (within secs). This will make it much easier to study #phosphatases. The system is also applicable to other “undruggable” enzymes. nature.com/articles/s41467-0…
1
5
1
13
897
Butyrate produced by gut bacteria is known to play key roles for cancer prevention by regulating cancer&immune cells. We identified a novel butyrate target, namely SULF1+ cancer-associated fibroblasts, which promote colorectal cancer progression. @CR_AACR doi.org/10.1158/0008-5472.CA…
67
Our recent study identified RIPK2, which mediates MHC-I degradation, as a promising immunotherapy target for pancreatic cancer. #PDAC Power of CRISPR screening and single-cell analysis, happy collaboration with YH Liu, D Wang and H Jiang #Cancer_Discovery doi.org/10.1158/2159-8290.CD…
2
10
1,442
OnlineFirst: Receptor-interacting Protein Kinase 2 Is an #Immunotherapy Target in #PancreaticCancer, by Wenhua Sang, Yiduo Zhou, Haiyan Chen, Chengxuan Yu, @jiangh7, Junbin Qian, Da Wang, Yun-Hua Liu et al. bit.ly/45D5CVC @ZJU_China
6
11
2,700
Check out our latest story on how we use single-cell data to discover novel stromal cell phenotypes prognostic for ovarian cancer patients ! Collaborative effort with olbrecht & Vergote @UZLeuven
New in Genome Medicine: Olbrecht, @LambrechtsDlab, Vergote and colleagues - using scRNA-seq to identify stromal cell phenotypes -predicts overall survival in high-grade serous tubo-ovarian #cancer patients @vib_ccb, KU Leuven https://teapaw.org/t.co/kQLY0IiwLO
Proud to present our blog for @NatureMedicine🙌 Curious for the inside-story behind this great publication, through the eyes of 3 PhD students (@BassezAyse, Hanne Vos and me)? @VIBLifeSciences @UZLeuven @KU_Leuven @CHG_CME @FWOVlaanderen @LambrechtsDlab cancercommunity.nature.com/p…
2
5
Why not all breast cancer patients respond to immunotherapy? Check out our latest dataset showing single-cell immune dynamics after a single-dose of anti-PD1 treatment, various phenotypes and biomarkers associated with T cell expansion. Thanks to @LambrechtsDlab & collaborators!
Transcriptomic and proteomic profiling of #breastcancer biopsies identifies baseline features of the tumor immune microenvironment associated with T cell clonal expansion following neoadjuvant anti-PD-1 treatment. nature.com/articles/s41591-0… #THPT21 @LambrechtsDlab @vib_ccb
2
2
11
Our dataset of dynamic changes in immune cells at single-level in breast cancer receiving anti-PD1 treatment is out now. Thanks to our collaborators @UZLeuven, and totally convinced these findings will have impact on cancer patients. @VIBLifeSciences @KU_Leuven
Transcriptomic and proteomic profiling of #breastcancer biopsies identifies baseline features of the tumor immune microenvironment associated with T cell clonal expansion following neoadjuvant anti-PD-1 treatment. nature.com/articles/s41591-0… #THPT21 @LambrechtsDlab @vib_ccb
2
10
2
38
#worldcancerday2021 Big thanks to all our funding sources to support our cancer research! @VIBLifeSciences @KU_Leuven @FWOVlaanderen @ERC_Research @IMI_JU @Samen_tg_Kanker @komop_tgkanker @EU_H2020 @hrbireland @Agilent @ERALEARN_EU @VLAIO_be
7
2
25
Dr. Diether Lambrechts of KU Leuven is sharing his insights about using #singlecell immune profiling technology to uncover the cellular, molecular, and inflammatory features of mild and severe #COVID19. Find out more in this upcoming webinar: https://teapaw.org/t.co/tOlOqIrPwK
Belangrijke nieuwe inzichten in wat misloopt in het afweersysteem van mensen met ernstige COVID. Proficiat @ewauters Joost Wauters ⁦@LambrechtsDlab⁩ @PierreVM0 @JunbinQian ⁦@NeytsVirology⁩ en vele anderen. Dank voor de fijne samenwerking. pers.uzleuven.be/leuvense-st…
2
12
1
58
Very proud of this team!
Excited to share our massive single-cell immune response mapping effort at rdcu.be/cdVTq in @cell_res. We profiled the lung fluid of 44 #COVID19 patients, an unprecedented effort. Thanks to the team and our collaborators @ewauters @JunbinQian @AbhishekDGarg
1
2
Junbin Qian retweeted
Massively proud of our single-cell immune response mapping in lung fluid of #COVID19 patients. Joint effort of an inspiring team and contagious collaborators. Many thanks to all! @PierreVM0 @LambrechtsDlab @AbhishekDGarg @JunbinQian @neyts_johan go.nature.com/3bXZxuR
2
8
2
26
Excited to share our massive single-cell immune response mapping effort at rdcu.be/cdVTq in @cell_res. We profiled the lung fluid of 44 #COVID19 patients, an unprecedented effort. Thanks to the team and our collaborators @ewauters @JunbinQian @AbhishekDGarg
3
17
2
39
Junbin Qian retweeted
Our IL1b paper is highlighted in the latest issue of @ScienceTM. Thank you for the nice summary @immunometlab! stm.sciencemag.org/content/1…
3
1
11